KIF3A and Alzheimer disease: Since KIF3A methylation at the newly generated rs11740584 and rs2299007 CpG sites was highly correlated with skin barrier dysfunction, specifically increased TEWL, KIF3A genotype and/or methylation at these sites may be clinically useful biomarkers of AD development in pregnancy or early life.